Related Experiment Video
Updated: Jun 24, 2026
10:03
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Adiponectin levels in coronary artery ectasia
Necati Dagli1, Unal Ozturk, Ilgin Karaca
1Department of Cardiology, Medical School, Firat University, Firat Tip Merkezi Kardiyoloji Anabilim Dali, Elazig, Turkey. mustafanecati46@hotmail.com
Heart and Vessels
|April 2, 2009
Summary
Coronary artery ectasia (CAE) is linked to lower adiponectin levels, suggesting this protein may play a role in its development. Low adiponectin may indicate increased risk for CAE, a condition related to atherosclerosis.
Area of Science:
- Cardiology
- Biochemistry
- Pathophysiology
Background:
- Coronary artery ectasia (CAE) is characterized by abnormal coronary artery dilation.
- The exact causes of CAE are unclear, but it is hypothesized to involve medial degeneration during atherosclerosis.
- Adiponectin, a protein hormone, is known to decrease in atherosclerotic heart disease.
Purpose of the Study:
- To compare adiponectin levels in patients with CAE versus those with normal coronary anatomy.
- To investigate the potential role of adiponectin in the etiopathogenesis of CAE.
Main Methods:
- The study included 66 participants: 36 with CAE and 30 with normal coronary anatomy.
- Serum adiponectin and high-sensitivity C-reactive protein levels were measured.
- Coronary artery diameters were assessed to define CAE, with abnormal segments 1.5 times larger than adjacent normal segments.
Main Results:
- Serum adiponectin levels were significantly lower in the CAE group (4.31 ± 2.02 μg/ml) compared to the normal anatomy group (6.73 ± 4.0 μg/ml) (P = 0.02).
- High-sensitivity C-reactive protein levels did not differ significantly between the groups (P > 0.05).
- A negative correlation was observed between ectatic coronary artery diameter and plasma adiponectin levels (P = 0.03; r = -0.339).
Conclusions:
- Low plasma adiponectin levels were found in acquired CAE, supporting a potential role in its etiopathogenesis and progression.
- Hypo-adiponectinemia may serve as an indicator of realized risk in CAE.
- Further large-scale, randomized, multicenter studies are needed to confirm adiponectin's role in CAE development.
Related Concept Videos
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...